The sequencing consumables market has seen considerable growth due to a variety of factors.
• The sequencing consumables market is projected to grow from $9.79 billion in 2024 to $12.44 billion in 2025, at a CAGR of 27.1%.
The rapid growth is driven by a rise in drug development activities, the growing prevalence of genetic disorders, increased use of miniaturized instruments, biomarker profiling, high demand for personalized medicine, and the rise in cancer patients.
The sequencing consumables market is expected to maintain its strong growth trajectory in upcoming years.
• The sequencing consumables market is expected to grow to $32.12 billion by 2029, at a CAGR of 26.8%.
This growth is attributed to the demand for rapid and accurate disease diagnosis, increasing real-time PCR adoption, demand for on-site diagnostic testing, infectious disease outbreaks, and companion diagnostics. Major trends include advanced disease detection, drug discovery innovations, biomarker identification, DNA sequencing technology advancements, and next-gen sequencing platforms.
The surge in genetic disorders is predicted to spur the development of the sequencing consumables market. Genetic disorders, often inherited, originate from abnormalities in a person's DNA or genes. The increasing occurrence of these disorders can be connected to rising awareness, enhanced diagnostics, and shifting environmental conditions. Sequencing consumables play a crucial role in genetic diseases management, as they are employed for DNA extraction, library preparation, sequencing and analysis to pinpoint genetic variants linked to the disease. For example, data from the Centers for Disease Control and Prevention, a US government agency, report that in April 2024, around 6,000 babies are born with Down syndrome each year in the U.S., meaning approximately 1 in every 700 babies have this condition. Consequently, the surge in genetic diseases is steering the expansion of the sequencing consumables market.
The sequencing consumables market covered in this report is segmented –
1) By Product: Kits, Reagents, Accessories
2) By Platform: 1st Generation Sequencing Consumables, 2nd Generation Sequencing Consumables, 3rd Generation Sequencing Consumables
3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics, Others Application
4) By End-Use: Pharmaceutical And Biotechnology Companies, Hospitals And Laboratories, Academic Research Institutes, Other End-Uses
Subsegments:
1) By Kits: Library Preparation Kits, DNA Or RNA Amplification Kits, Sequencing Kits
2) By Reagents: PCR Reagents, DNA Or RNA Reagents, Enzymes
3) By Accessories: Sequencing Chips, Primers And Probes, Sample Preparation Tools
Large firms participating in the sequencing consumables industry are prioritizing the creation of innovative techniques like human whole-genome sequencing (WGS) assays with a goal to upscale precision, effectiveness, and pace in the genomic studies. The human whole-genome sequencing (WGS) assays delves into a complete examination of an individual's full genome, encapsulating their complete DNA to detect genetic variations, mutations, and biomarkers that could be linked to health, susceptibility to disease, and response to treatment. For example, in March 2023, the American biotech firm, Illumina Inc., introduced their product, Illumina Complete Long Read Prep- Human. This product is a high-performance, long-read, human whole-genome sequencing (WGS) assay. This product is designed to work with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. It gives users the first-ever opportunity to access both long and short read data through one singular Illumina device. This new release simplifies processes while also significantly cutting down on DNA input conditions when compared to other long-read alternatives.
Major companies operating in the sequencing consumables market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Becton
• Dickinson and Company
• Agilent Technologies Inc.
• Illumina Inc.
• PerkinElmer Inc.
• bioMérieux SA
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Tecan Group AG
• BGI Genomics Co Ltd.
• Promega Corporation
• Abcam Limited
• Integrated DNA Technologies Inc.
• Takara Bio Inc.
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California Inc.
• Analytik Jena GmbH
• Standard BioTools Inc.
• LGC Biosearch Technologies Inc.
• Biocartis SA
• Apex Biotechnology Corp.
• Lexogen GmbH
North America was the largest region in the sequencing consumables market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sequencing consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.